Subjective endpoints in clinical trials: the case for blinded independent central review - Document - Gale Academic OneFile
![Challenging Issues in Clinical Trial Design: Part 4 of a 4-Part Series on Statistics for Clinical Trials - ScienceDirect Challenging Issues in Clinical Trial Design: Part 4 of a 4-Part Series on Statistics for Clinical Trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109715071995-gr1.jpg)
Challenging Issues in Clinical Trial Design: Part 4 of a 4-Part Series on Statistics for Clinical Trials - ScienceDirect
Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal
![Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) | BMJ Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) | BMJ](https://bmjopen.bmj.com/content/bmjopen/9/3/e026053/F2.large.jpg?width=800&height=600&carousel=1)
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) | BMJ
![Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events | Trials | Full Text Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-020-04254-w/MediaObjects/13063_2020_4254_Fig2_HTML.png)
Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events | Trials | Full Text
![Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: Methodology and external validation - ScienceDirect Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: Methodology and external validation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1551714412002066-gr1.jpg)
Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: Methodology and external validation - ScienceDirect
![2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee](https://www.jacc.org/cms/asset/46687fae-40d6-4e01-998d-f5f96a5328ac/j.jacc.2014.12.018.fp.png)